Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

First human trial yields positive data on L-dT, a potential new therapy for HBV

Jan. 11, 2002

Gastric and cholecystokinin receptor ligands claimed in patents by James Black researchers

Jan. 10, 2002

Cell adhesion inhibitor IS-741 effective in rat model of IBD

Jan. 10, 2002

Specific, small-molecule inhibitor of P-selectin with antiinflammatory properties

Jan. 10, 2002

Actimmune enters phase II trial for treatment of liver fibrosis

Jan. 10, 2002

ICN files IND for viramidine

Jan. 9, 2002

LY-570310, a new oral hepatitis C protease inhibitor, designated a development candidate

Jan. 8, 2002

Nucleotide inhibitors of HBV replication under development at Origenix

Jan. 8, 2002

Early clinical data indicate safety and efficacy of ISS-1018 coadministered with HBsAg

Jan. 8, 2002

Motilin antagonists disclosed at Ortho-McNeil

Jan. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...